Michael S Luck

Title: Michael S. Luck: Innovator in Colonic Delivery Systems

Introduction

Michael S. Luck is a notable inventor based in Cape Elizabeth, ME (US). He has made significant contributions to the field of pharmaceutical delivery systems, particularly focusing on the colonic delivery of protein and peptide compositions. His innovative approach aims to enhance the effectiveness of therapeutic agents by ensuring their targeted delivery to the colon.

Latest Patents

Michael S. Luck holds a patent for a method of delivering an active protein or peptide to the colon. This patent, titled "Colonic delivery of protein or peptide compositions," outlines a comprehensive method that includes several steps. The process involves creating a multiparticulate dosage core particle with specific components, including an aqueous PEG solution and a homogenous mixture of the active protein or peptide with microcrystalline cellulose. The method emphasizes the importance of precise measurements and conditions to ensure the successful delivery of therapeutic agents, particularly immunoglobulins, to the colon.

Career Highlights

Michael S. Luck is associated with Immucell Corporation, where he continues to work on innovative solutions in the pharmaceutical field. His expertise in drug delivery systems has positioned him as a key figure in advancing therapeutic methodologies. His dedication to research and development has led to significant advancements in the way proteins and peptides are delivered within the body.

Collaborations

Michael collaborates with Joseph H. Crabb, contributing to the development of innovative solutions in their field. Their combined efforts aim to push the boundaries of current pharmaceutical practices and improve patient outcomes.

Conclusion

Michael S. Luck's work in colonic delivery systems represents a significant advancement in pharmaceutical technology. His innovative methods and dedication to research continue to influence the field positively.